United States News All stories

Gilead Sciences (NASDAQ:GILD) announced that the European Commission approved Trodelvy (sacituzumab govitecan-hziy) combined with Keytruda (pembrolizumab) for adults with PD-L1-positive metastatic triple-negative breast cancer.

Precision BioSciences (NASDAQ:DTIL) announced that the first patient has been dosed in the Phase 1/2 FUNCTION-DMD trial evaluating PBGENE-DMD for Duchenne muscular dystrophy.

Comstock (NYSE:LODE) announced the completion of its sale of legacy mining, processing, and related real estate entities to Mackay Precious Metals, a subsidiary of Mackay Gold & Silver Corp., in a transaction valued at more than $45 million.

XPENG (NYSE:XPEV) announced that its robotics business has secured more than US$900 million in funding from global investors, giving the unit a post-money valuation of more than US$6.3 billion.

Ecovyst, ECVT stock, Laurie Bergman, CFO appointment, Michael Feehan, corporate leadership, executive changes, chemical industry

Robo.ai (NASDAQ:AIIO) reported net revenue of US$55.1 million for the six months ended June 30, 2026.

X Financial (NYSE:XYF) reported second-quarter 2026 total net revenue of RMB993.6 million (US$146.4 million), marking a 56.3 percent year-over-year decline.

Tanker traffic through the Strait of Hormuz remained weak over the weekend, with fewer than 20 vessels crossing the key oil route as Iran and the United States exchanged threats.

Oculis (NASDAQ:OCS) announced that the first patient has been treated in PIONEER-1, a registrational trial evaluating Privosegtor for acute optic neuritis in patients with and without multiple sclerosis.

Endeavour Silver (NYSE:EXK) announced that the blockade at its Terronera Mine in Mexico has been removed, allowing operations at the site to resume on August 24, 2026.

Takeda (NYSE:TAK) announced that Japan’s Ministry of Health, Labour and Welfare approved ORZEYFUL (oveporexton) for adults with narcolepsy type 1, making it the company’s third global approval for the treatment.

Acadia Pharmaceuticals (NASDAQ:ACAD) announced that the European Commission approved DAYBU (trofinetide) for Rett syndrome in adults and pediatric patients aged five years and older, making it the first approved Rett syndrome treatment in the European Union.

Descartes Systems Group (NASDAQ:DSGX) acquired the transportation management system provider Tai for $100 million to expand its logistics capabilities for freight brokers.

La Rosa Holdings (NASDAQ:LRHC) reported first-half 2026 revenue of $28.6 million, down from $34.9 million in 2025, while gross profit increased and operating losses narrowed.

Biogen (NASDAQ:BIIB) and Eisai announced that LEQEMBI IQLIK, a once-weekly subcutaneous lecanemab-irmb autoinjector, is now available in the United States for adults with early Alzheimer’s disease.

Kimbell Royalty Partners (NYSE:KRP) issued updated third and fourth quarter 2026 guidance after completing the Mesa Acquisition and Drop Down transaction, valued at approximately $145.9 million and $221.2 million respectively.

• The Home Depot (NYSE:HD) reported fiscal Q2 2026 sales of $47.9 billion, up 5.7%, as comparable sales increased 1.7%.
• Lowe’s, Tractor Supply, Floor & Decor and Williams-Sonoma are facing similar consumer spending pressures across home projects, repairs and discretionary purchases.
• The sector outlook depends on housing activity, interest rates, consumer confidence and whether delayed renovation demand returns.

• Target (NYSE:TGT) reported $26.5 billion in second-quarter net sales, up 5.3%, while $994 million in tariff refunds lifted diluted EPS to $4.11.
• Large U.S. value retailers are still growing sales, but profitability varies sharply as companies balance pricing, digital fulfillment and operating costs.
• Tariffs, fuel and freight costs, consumer price sensitivity and aggressive value positioning remain key variables for the sector through 2026.

• Gina Rinehart's Hancock Prospecting purchased eight million shares of SpaceX for US$1.37 billion. The firm stated this diversifies its portfolio away from Western Australian mining operations.
• The transaction drove a 72% increase in the firm's US equities portfolio to US$5.71 billion. These listed space peers share massive capitalisation metrics driven by institutional tech allocations.
• Developing orbital infrastructure requires extreme capital intensity. Aerospace executives project that scaling launch vehicles will demand continuous funding before reaching profitability.

• Klarna posted Q2 2026 revenue of $1.042 billion (+27%) and GMV of $36.6 billion (+18%), while turning a $46 million operating loss a year earlier into a $27 million operating profit and $9 million net income.
• Despite stronger profitability and transaction margins, Klarna cut its full‑year GMV outlook to $149–151 billion, citing weaker German consumer spending and ongoing sensitivity to credit conditions.
• Compared with peers, Klarna is larger than Affirm and Sezzle on GMV but faces similar pressure to show that higher per‑transaction economics can offset slower volume growth, while Block and PayPal embed BNPL within much broader payments ecosystems.

Scholar Rock (NASDAQ:SRRK) removed Catalent Indiana as a commercial fill-finish facility from its apitegromab Biologics License Application (BLA) for spinal muscular atrophy (SMA), with FDA review continuing using an alternate facility.

Yatra Online (NASDAQ:YTRA) confirmed that Magna Holdings launched an unsolicited tender offer to purchase up to 20 million ordinary shares of Yatra at $1.10 per share in cash.

Alvotech (NASDAQ:ALVO) entered a strategic licensing and commercialization agreement with Lotus Pharmaceutical covering two biosimilar candidates, AVT34 and AVT87, with potential value of approximately $150 million.

FedEx (NYSE:FDX) declared a quarterly cash dividend of $1.22 per share on common stock, payable on October 1, 2026, to shareholders of record as of September 14, 2026.